In one study, inhibition of COX-2 expression significantly relieved dysmenorrhea symptoms, while overexpression of COX-2 was significantly correlated with dysmenorrhea symptoms in adenomyosis (Li et al., 2019). This evidence concerns the gene PTGS2 and adenomyosis.